journal article·2016-11-16Open access

Different expression of miR-29b and VEGFA in glioma

Qiang Liu, Fan Liao, Hao Wu, Tao Cai, Liang Yang, Jiasheng Fang

Abstract

Glioma is one of the most common carcinomas in terms of both incidence and mortality worldwide. This is a case-control study with 240 cases and age- and gender-matched controls in the rate of 1:1. The results of this present word indicated that the expressions of both miR-29b and VEGFA in blood were significantly different compared with the control group, and thus may help to differentiate glioma cases from the controls. In addition, the diagnostic role of miR-29b and VEGFA was important for the clinical application. In conclusion, circulating miR-29b and VEGFA could be used as diagnosis biomarkers.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: MicroRNA in disease regulation · Circular RNAs in diseases · Cancer-related molecular mechanisms research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (29)

Show source-provided references
1. 10.1371/journal.pone.007709810.1371/journal.pone.0077098 ↗
2. 10.3171/2014.9.FOCUS1452010.3171/2014.9.FOCUS14520 ↗
3. 10.1016/j.bbrc.2014.10.11310.1016/j.bbrc.2014.10.113 ↗
4. Chen T · Mol Med Rep · 2015 · 11 · 240710.3892/mmr.2014.3027 ↗
5. 10.1038/ncb267210.1038/ncb2672 ↗
6. 10.1002/gcc.2080810.1002/gcc.20808 ↗
7. 10.1158/1940-6207.CAPR-13-026310.1158/1940-6207.CAPR-13-0263 ↗
8. 10.1016/j.gene.2015.04.06510.1016/j.gene.2015.04.065 ↗
9. 10.1177/019262331560124510.1177/0192623315601245 ↗
10. 10.1111/cns.1235410.1111/cns.12354 ↗
11. 10.1042/CS2012012110.1042/CS20120121 ↗
12. 10.4238/2015.August.28.1410.4238/2015.August.28.14 ↗
13. 10.1016/j.toxlet.2014.11.01110.1016/j.toxlet.2014.11.011 ↗
14. 10.7314/APJCP.2013.14.12.755110.7314/APJCP.2013.14.12.7551 ↗
15. 10.3171/2014.9.FOCUS1467110.3171/2014.9.FOCUS14671 ↗
16. 10.1097/PPO.000000000000008110.1097/PPO.0000000000000081 ↗
17. 10.1371/journal.pone.007762310.1371/journal.pone.0077623 ↗
18. 10.1093/neuonc/nov11410.1093/neuonc/nov114 ↗
19. 10.1002/ejhf.33210.1002/ejhf.332 ↗
20. 10.1371/journal.pone.007503410.1371/journal.pone.0075034 ↗
21. 10.1007/s00345-012-1010-210.1007/s00345-012-1010-2 ↗
22. Shinden Y · Mol Clin Oncol · 2015 · 3 · 91910.3892/mco.2015.565 ↗
23. 10.1186/s12885-015-1538-910.1186/s12885-015-1538-9 ↗
24. 10.1038/cddis.2014.30410.1038/cddis.2014.304 ↗
25. 10.1002/iub.127310.1002/iub.1273 ↗
26. 10.1186/1471-2377-13-12410.1186/1471-2377-13-124 ↗
27. Xiao J · Int J Clin Exp Med · 2014 · 7 · 136
28. 10.1177/030006051350526610.1177/0300060513505266 ↗
29. Zhang K · Int J Clin Exp Pathol · 2014 · 7 · 5701